Servier's Mediator 'probably responsible for 1,300 deaths'
This article was originally published in Scrip
Servier's Mediator (benfluorex), the product at the centre of the French regulatory storm, was probably responsible for around 1,300 deaths and 3,100 hospitalisations due to heart valve damage, according to a new French study.
You may also be interested in...
Products from Novartis, Celgene and Merck could get an EU approval recommendation at this week's CHMP meeting.
The EU’s new health commissioner, Stella Kyriakides, has outlined the commission’s plans for dealing with medicines access issues in the EU member states. They include completing the review of the EU pediatric and orphan legislation and developing a new strategic plan to tackle shortages and affordability problems next year.
AstraZeneca’s Lynparza can now be used on the Scottish National Health Service for newly diagnosed advanced ovarian cancer.